Cargando…

Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis?

Liver injury has been reported in coronavirus disease 2019 (COVID-19) cases but the impact of pre-existing liver damage and related etiology have not been completely elucidated. Our research interests include the potential reciprocal influence of COVID-19 and pre-existing liver damage related to hep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mangia, Alessandra, Cenderello, Giovanni, Verucchi, Gabriella, Ciancio, Alessia, Fontana, Andrea, Piazzolla, Valeria, Minerva, Nicola, Squillante, Maria Maddalena, Copetti, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716316/ https://www.ncbi.nlm.nih.gov/pubmed/33344581 http://dx.doi.org/10.12998/wjcc.v8.i22.5831

Ejemplares similares

SVR12 Higher than 97% in GT3 Cirrhotic Patients with Evidence of Portal Hypertension Treated with SOF/VEL without Ribavirin: A Nation-Wide Cohort Study
por: Mangia, Alessandra, et al.
Publicado: (2019)

Durability of immune response to SARS-CoV-2 vaccination in patients with liver cirrhosis (LC) as compared to healthcare workers (HW)
por: Mangia, Alessandra, et al.
Publicado: (2022)

Nonalcoholic Steatohepatitis: A 9-Year Follow Up Cohort Study
por: Mangia, Alessandra, et al.
Publicado: (2022)

Hepatitis C virus micro-elimination: Where do we stand?
por: Mangia, Alessandra, et al.
Publicado: (2021)

Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis
por: Mangia, Alessandra, et al.
Publicado: (2018)

Effectiveness of Booster Dose of Anti SARS-CoV-2 BNT162b2 in Cirrhosis: Longitudinal Evaluation of Humoral and Cellular Response
por: Giambra, Vincenzo, et al.
Publicado: (2022)

Early Serological Response to BNT162b2 mRNA Vaccine in Healthcare Workers
por: Cocomazzi, Giovanna, et al.
Publicado: (2021)

HDV RNA Levels and Progression of Hepatitis Delta Infection: A 14 Year Follow Up Experience in Italy
por: Mangia, Alessandra, et al.
Publicado: (2023)

Individualized Treatment of Genotype 1 Naïve Patients: An Italian Multicenter Field Practice Experience
por: Mangia, Alessandra, et al.
Publicado: (2014)

Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020)

Increased Hepatitis C virus screening, diagnosis and linkage to care rates among people who use drugs through a patient‐centered program from Italy
por: Mangia, Alessandra, et al.
Publicado: (2021)

SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience
por: Mangia, Alessandra, et al.
Publicado: (2019)

Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience
por: Mangia, Alessandra, et al.
Publicado: (2019)

Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose
por: Mangia, Alessandra, et al.
Publicado: (2022)

COVID-19 vaccination among cirrhotics in Italy: High coverage and effectiveness of 3 doses versus 2 in preventing breakthrough infection and hospitalization
por: Stroffolini, Tommaso, et al.
Publicado: (2023)

High Rates of Hidden HCV Infections among Hospitalized Patients Aged 55–85
por: Piazzolla, Annarita Valeria, et al.
Publicado: (2021)

437 A TAILORED PROGRAM FOR SCREENING, IMPROVED ACCESS TO CARE, AND PRIORITIZATION OF TREATMENT FOR PWUD WITH CHRONIC HCV INFECTION.
por: Mangia, Alessandra, et al.
Publicado: (2021)

Long-Term Hepatocellular Carcinoma Development and Predictive Ability of Non-Invasive Scoring Systems in Patients with HCV-Related Cirrhosis Treated with Direct-Acting Antivirals
por: Caviglia, Gian Paolo, et al.
Publicado: (2022)

CMV-Specific Cell-Mediated Immunity in Immunocompetent Adults with Primary CMV Infection: A Case Series and Review of the Literature
por: Chiereghin, Angela, et al.
Publicado: (2021)

IL28B genotype is associated with cirrhosis or transition to cirrhosis in treatment-naive patients with chronic HCV genotype 1 infection: the international observational Gen-C study
por: Mangia, Alessandra, et al.
Publicado: (2016)

Identifying Predictors Associated with Risk of Death or Admission to Intensive Care Unit in Internal Medicine Patients with Sepsis: A Comparison of Statistical Models and Machine Learning Algorithms
por: Mirijello, Antonio, et al.
Publicado: (2023)

Interobserver agreement of the Paris and simplified classifications of superficial colonic lesions: a Western study
por: Cocomazzi, Francesco, et al.
Publicado: (2021)

Prognostic Role of Bacterial and Fungal Infections in Patients With Liver Cirrhosis With and Without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study
por: Bartoletti, Michele, et al.
Publicado: (2020)

RISK OF PRENEOPLASTIC LESIONS IN MUCOSAL PROJECTIONS OF DIFFERENT SIZES OF THE COLUMNAR EPITHELIUM IN THE LOWER ESOPHAGUS
por: Copetti, Hairton, et al.
Publicado: (2022)

Microwave Ablation in Intermediate Hepatocellular Carcinoma in Cirrhosis: An Italian Multicenter Prospective Study
por: Giorgio, Antonio, et al.
Publicado: (2018)

Chronic migraine long-term regular treatment with onabotulinumtoxinA: a retrospective real-life observational study up to 4 years of therapy
por: Santoro, Antonio, et al.
Publicado: (2020)

Progression of liver cirrhosis to HCC: an application of hidden Markov model
por: Bartolomeo, Nicola, et al.
Publicado: (2011)

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program
por: Calvaruso, Vincenza, et al.
Publicado: (2019)

Screening and surveillance of oesophageal varices in patients with HCV‐positive liver cirrhosis successfully treated by direct‐acting antiviral agents
por: Ciancio, Alessia, et al.
Publicado: (2022)

Impaired cognition predicts the risk of hospitalization and death in cirrhosis
por: Kim, Minjee, et al.
Publicado: (2019)

Acute kidney injury is independently associated with death in patients with cirrhosis
por: Scott, Robert A, et al.
Publicado: (2013)

Seroprevalence of hepatitis A antibodies in patients with cirrhosis of liver
por: Jain, Mayank
Publicado: (2022)

Target Values of Cardiovascular Risk Factors Are Not Associated with All-Cause Mortality in Patients with Type 2 Diabetes Mellitus
por: Pacilli, Antonio, et al.
Publicado: (2015)

Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting
por: Santoro, Antonio, et al.
Publicado: (2017)

Vitamin D serum level in subjects with critical illness polyneuropathy and myopathy
por: Intiso, Domenico, et al.
Publicado: (2020)

Is cirrhosis associated with lower odds of ischemic stroke: A nationwide analysis?
por: Goyal, Abhinav, et al.
Publicado: (2016)

Women with cirrhosis have lower self-rated health than men
por: Wang, Melinda, et al.
Publicado: (2023)

Treatment of hepatitis C virus genotype 4 in the DAA era
por: Di Biagio, Antonio, et al.
Publicado: (2018)

Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes
por: Ortega Moreno, Lorena, et al.
Publicado: (2016)

Impact of healthcare-associated infections on functional outcome of severe acquired brain injury during inpatient rehabilitation
por: Bartolo, Michelangelo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qe1impgjnnnsn6l88grdekhbpj